The management of schizophrenia.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002090:Butyrophenones / Q000627:therapeutic use; D003156:Community Mental Health Services; D004739:England; D006760:Hospitalization; D006801:Humans; D008884:Milieu Therapy; D010640:Phenothiazines; D011613:Psychotherapy; D012559:Schizophrenia / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D012931:Social Environment
D014150:Antipsychotic Agents; D002090:Butyrophenones; D010640:Phenothiazines